TickerFactsScreenerDevelopers

Rein Therapeutics, Inc. (RNTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$20.53M2018: -$27.93M2019: -$26.47M2020: -$20.48M2021: -$23.75M2022: -$24.86M2023: -$19.81M2024: -$22.29M2025: -$19.36M-$19.36M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$19.36M+13.1%
2024-$22.29M-12.5%
2023-$19.81M+20.3%
2022-$24.86M-4.7%
2021-$23.75M-16.0%
2020-$20.48M+22.7%
2019-$26.47M+5.2%
2018-$27.93M-36.0%
2017-$20.53M—